anonymous
Guest
anonymous
Guest
Sales limped in at 13 million in double digit billion dollar market. Nothing said about how we can get this stock back to the $50.00 range. Much chest beating about adding another board member and bragging about an outcomes trial everyone is waiting until mid 2023 to be released. Esperion isn't covering operating expenses from sales revenue. The shorts were totally in play yesterday and today. There was nothing to be proud of in this quarterly report.